179060-34-5

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 150322-87-5 4,5,6,7-tetrahydrofuro[3,2.-c]pyridine 
• 98-01-1 furfural 
• 699-18-3 2-(2-nitrovinyl)furan 
• 1121-46-6 2-Furan-2-yl-ethylamine 
• 1373492-28-4 C₇H₁₁NO₂ 

Downstream Products

• 1373491-81-6 8-(2-chlorophenyl)-8-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethyloctanoic acid ethyl ester 
• 1373491-54-3 8-(2-chlorophenyl)-8-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethyloctanoic acid hydrochloride 
• 1373491-76-9 7-(2-chlorophenyl)-7-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethylheptanoic acid ethyl ester 
• 1373491-58-7 7-(2-chlorophenyl)-7-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethylheptanoic acid hydrochloride 

Relevant academic research and scientific papers

PROBES FOR IMAGING HUNTINGTIN PROTEIN

Provided are imaging agents comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof, and methods of their use. Formula (I)

COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILISATION

The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.